Thyrocare Technologies Share History & Returns 2016 to 2024
Thyrocare Technologies Limited | |||
 | Price: ₹950.30 | ||
| 52 Week Low: ₹554.10 52 Week High: ₹1,050.15 | |||
| Market Capital: 3,332.02 Crore (Smallcap) | |||
| Healthcare -> Diagnostics & Research | |||
Show Table of Contents
Table of Contents
- 1: Thyrocare Technologies Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Thyrocare Technologies Recent Performance
- 3: Thyrocare Technologies Stock Price Chart From 2016 to 2024
- 4: Thyrocare Technologies Stock Price History Table From 2016 to 2024
- 5: Analyzing the Impact of Investing in Thyrocare Technologies
- 5.1: Thyrocare Technologies Stock Returns In Last 5 Years
- 6: Thyrocare Technologies Returns vs Bank FD Returns
Thyrocare Technologies Stock Highlights
As of 20 Dec 2024, Thyrocare Technologies Stock price is ₹950.30 which is ₹99.85 below 52-week high of ₹1,050.15 and ₹396.20 above 52-week low of ₹554.10
52-Week High Low
- Thyrocare Technologies 52-Week High is ₹1,050.15 occurred on 04 Dec 2024
- Thyrocare Technologies 52-Week Low is ₹554.10 occurred on 27 Mar 2024
All Time High
- The all-time high or the highest price that Thyrocare Technologies stocks have ever touched was ₹1,465.00 and this occurred on 25 Jun 2021.
- The highest closing price at which Thyrocare Technologies stocks have ever closed was ₹1,448.09 recorded on 25 Jun 2021.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Thyrocare Technologies Recent Performance
Over the past 15 trading days, the value of Thyrocare Technologies's stock has decreased by ₹27.20 (-2.78%). On 28 Nov 2024, its one share was worth ₹977.5 and by 20 Dec 2024, the value dropped to ₹950.3. During this period it created a highest high of ₹1049.90 and lowest low of ₹943.25.
Click on legend items to show/hide respective price lines
Thyrocare Technologies Stock Price Chart From 2016 to 2024
Click on legend items to show/hide respective price lines
Thyrocare Technologies Stock Price History Table From 2016 to 2024
| Year | Thyrocare Technologies | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹950.30 | 47.6% | ↑ ₹1,049.00 ↓ ₹943.00 |
| 2023 | ₹643.55 | 4.0% | ↑ ₹689.00 ↓ ₹415.00 |
| 2022 | ₹618.65 | -44.2% | ↑ ₹1,132.00 ↓ ₹600.00 |
| 2021 | ₹1,107.55 | 21.3% | ↑ ₹1,465.00 ↓ ₹831.00 |
| 2020 | ₹913.00 | 66.2% | ↑ ₹1,212.00 ↓ ₹409.00 |
| 2019 | ₹549.15 | 1.7% | ↑ ₹604.00 ↓ ₹407.00 |
| 2018 | ₹539.55 | -22.9% | ↑ ₹724.00 ↓ ₹524.00 |
| 2017 | ₹699.10 | 0.8% | ↑ ₹871.00 ↓ ₹641.00 |
| 2016 | ₹693.25 | - | ↑ ₹720.00 ↓ ₹523.00 |
Analyzing the Impact of Investing in Thyrocare Technologies
Thyrocare Technologies Stock price in the year 2016 was ₹693.25. If you had invested ₹10,000 in Thyrocare Technologies Stock in 2016, in 8 years, your investment would have grown to ₹13,707 by the end of 2024. This represents a positive return of 37.0% from 2016 to 2024, with a compound annual growth rate (CAGR) of 4%.
Thyrocare Technologies Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹1,465.00 and lowest was: ₹407.15
- Thyrocare Technologies Stock price in 2019 was ₹549.15
- By 2024, its stock price rose to ₹950.30
- It gave a positive return of over 73.0% with a CAGR of 11.6% over the last 5 years
- If you had invested ₹10,000 in Thyrocare Technologies in 2019 then in 5 years, your investment would have grown to ₹17,304.92 by 2024, which is 1.73 times of your initial investment.
Thyrocare Technologies Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Thyrocare Technologies Shares | ₹10,000 | ₹13,707.89 | 37.1% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,800 | 48.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,938.48 | 59.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
